What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!

Monday: A report said that the total value of crowdfunded Biotech projects from within the EU since 2010 is €23M.

Tuesday: Researchers from University of Leeds unraveled the mechanism of cancer-targeting effects of Wasp venom.

Wednesday: Kymab has been listed in the Sunday Times Tech Track ‘One’s to Watch’ 2015 just this month!

Thursday: CureVac just announced the opening of its subsidiary in Boston and a research collaboration to develop a mRNA-based HIV treatment.

Friday: Cambridge biotech leader Abcam and Horizon Discovery finally came together to partner up on antibody research

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.